(132 days)
Not Found
No
The device description and performance studies focus on the physical properties, materials, and clinical performance of contact lenses, with no mention of AI or ML technology.
Yes
The device is indicated for correcting visual acuity, which is a therapeutic purpose, and one of its uses is to provide improved comfort for contact lens wearers experiencing discomfort or symptoms related to dryness during lens wear associated with Evaporative Tear Deficiency or Aqueous Tear Deficiency. Addressing symptoms of a deficiency falls under therapeutic indications.
No
Explanation: The "Intended Use / Indications for Use" section states that the device is "indicated for daily wear for the correction of visual acuity" for various refractive errors and presbyopia and provides "improved comfort." This indicates a therapeutic or corrective function, not a diagnostic one. There is no mention of the device identifying or detecting a disease or condition.
No
The device is a physical contact lens made of a polymer material, not software. The description details its physical properties, materials, and manufacturing process.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the contact lenses are for the "correction of visual acuity" in individuals with various refractive errors and presbyopia. This is a therapeutic or corrective function, not a diagnostic one.
- Device Description: The description details the physical composition and design of the contact lenses, which are designed to alter the way light enters the eye to improve vision.
- Lack of Diagnostic Function: There is no mention of the device being used to diagnose a disease, condition, or state of health. It does not analyze samples from the human body (in vitro) to provide diagnostic information.
- Clinical Studies: The studies mentioned focus on physicochemical properties, toxicology, and biocompatibility, which are relevant to the safety and performance of a medical device intended for wear on the eye, but not for diagnostic accuracy.
IVD devices are specifically designed to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. Contact lenses, while medical devices, do not fit this definition.
N/A
Intended Use / Indications for Use
Proclear Multifocal Toric (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with nondiseased eyes that are myopic or hyperopic which, possess astigmatism to -5.75 diopters or less, and are presbyopic.
Proclear Multifocal XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with nondiseased eyes that are myopic or hyperopic and are presbyopic. The lenses may be worn by persons who exhibit astigmatism of 0.75 diopters or less that does not interfere with visual acuity.
Proclear Toric XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with non-diseased eyes that are myopic or hyperopic which possess astigmatism corrections to -5.75 diopters.
Proclear Sphere and Asphere: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in non-aphakic persons with nondiseased eyes that are myopic or hyperopic and exhibit astigmatism of 2.00D or less that does not interfere with visual acuity.
Proclear Toric: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in non-aphakic persons with non-diseased eyes that are myopic or hyperopic The lens may be worn by persons who have astigmatism of 5.00D or less.
Proclear Multifocal: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of refractive ametropia (myopia, and astigmatism) and presbyopia in non-aphakic persons with non-diseased eyes. The lens may be worn by persons who have astigmatism of 2.00D or less that does not interfere with visual acuity.
Proclear (omafilcon A) Soft (hydrophilic) Contact Lenses may provide improved comfort for contact lens wearers who experience mild discomfort or symptoms related to dryness during lens wear associated with Evaporative Tear Deficiency or from Aqueous Tear Deficiency (non-Sjogren's only).
Daily wear replacement schedules may vary from patient and should be decided by eyecare practitioners in consultation with their patients.
Product codes (comma separated list FDA assigned to the subject device)
LPL and MVN
Device Description
The Proclear lens is composed of polymer of 2-hydroxy-ethylmethacrylate and 2-metacryloloyoxyethyl phosphorylcholine cross linked with ethylene glycol dimethacrylate. The lenses are tinted blue from edge to edge for visibility purposes. The Proclear (omafilcon A) Soft (hydrophilic) contact lenses are a hemispherical shell. The physical properties and available dimensions are unchanged from predicate 510ks.
Proclear Toric and Proclear Toric XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are back surface toric.
Proclear Multifocal and Proclear Multifocal XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are available as a multifocal lens with an aspherical front surface and spherical back surface for the correction of visual acuity in presbyopic persons who are myopic or hyperopic. The multifocal lens has two multifocal zones, as well as the edge shape being optimized to provide comfort without sacrificing tensile strength.
Proclear Multifocal Toric (omafilcon A) Soft (Hydrophilic) Contact Lens front surface is aspherical, with the anterior surface having a toric generated surface for the purpose of correcting vision in an eve that is astigmatic.
Proclear Sphere and Asphere: (omafilcon A) Soft (hydrophilic) Contact Lenses. The sphere lenses have spherical optical zone and asphere lens have an aspherical optical zone. This aspheric optical zone design (front surface) controls and limits the amount of longitudinal spherical aberration generated by the lens across the power range.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
eyes / ocular environment
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Daily wear replacement schedules may vary from patient and should be decided by eyecare practitioners in consultation with their patients.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Physicochemical Studies:
- Study Type: Physicochemical property testing per ISO 18369-4:2006.
- Key Results: "Results from physical, optical and chemical properties were performed and indicate no change to physicochemical properties of the lenses." All tested characteristics (Total Extractables, Water content, Dk, Light Transmittance, Refractive Index) met acceptance criteria and were "Equivalent to predicate lens and meet tolerances in ISO 18369-2:2006". "All the material characteristics for the omafilcon A lens are equivalent between the predicate lens and the subject lens."
Toxicology Studies:
- Study Type: In-vivo and in-vitro toxicology and biocompatibility studies conducted in accordance with GLP regulation (21 CFR Part 56) or valid scientific protocols.
- Tests Performed:
- Cytotoxicity Test ISO 10993 - 5:1999
- ISO Ocular Irritation ISO 10993 - 10:2002
- Systemic Toxicity Study ISO 10993 - 11:1996
- ISO Contact Lens 22 Day Ocular Irritation Study ISO 9394
- Key Results: "Results from in-vivo and in-vitro studies were performed as support for this modification and indicate no issues of toxicity or biocompatibility with the modified lens. Change will not affect lenses ability to remain non-toxic and biocompatible with the ocular environment." All tests passed their respective acceptance criteria.
Clinical Studies:
- Study Type: Not performed.
- Key Results: "The technical characteristics, formulation, manufacturing, and sterilization processes of this lens are not changing and are equivalent to omafilcon A soft contact lenses currently marketed by CooperVision, therefore no clinical data is required."
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
DEC 2 1 2011
Image /page/0/Picture/2 description: The image shows the CooperVision logo. The logo consists of the word "CooperVision" in a bold, sans-serif font. To the left of the word is a stylized "C" symbol, and to the right is a black square with a white swirl inside. The logo is simple and modern, and the black and white color scheme gives it a clean and professional look.
510(k) Summary K112302
| 1.
Applicant Name and
Address | CooperVision, Inc.
6150 Stoneridge Mall Drive
Suite 370
Pleasanton CA 94588 | |
|-------------------------------------|-------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------|
| 2. Contact | Lisa Hahn
Global Regulatory Affairs
585-385-6810 ext 4221
Ihahn@coopervision.com | |
| 3. Date Prepared | October 17, 2011 | |
| 4. Device Identification | Trade Name: | Proclear |
| | Common Name: | Scheduled Replacement Soft Contact
Lenses for Daily wear or Daily
Disposable Soft Contact Lenses |
| | Classification
Name: | Daily Wear, Soft (hydrophilic) Contact
Lenses |
| | Device
Classification: | Class II (21 CFR 886.5925) |
| | FDA Material
Class: | FDA Group II Non-Ionic High Water
Content |
| | Product Code: | LPL and MVN |
5. Device Description
The Proclear lens is composed of polymer of 2-hydroxy-ethylmethacrylate and 2-metacryloloyoxyethyl phosphorylcholine cross linked with ethylene glycol dimethacrylate. The lenses are tinted blue from edge to edge for visibility purposes. The Proclear (omafilcon A) Soft (hydrophilic) contact lenses are a hemispherical shell. The physical properties and available dimensions are unchanged from predicate 510ks.
Proclear Toric and Proclear Toric XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are back surface toric.
Proclear Multifocal and Proclear Multifocal XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are available as a multifocal lens with an aspherical front surface and spherical back surface for the correction of
CooperVision 510(k) Summary - Proclear omafilcon A
1
visual acuity in presbyopic persons who are myopic or hyperopic. The multifocal lens has two multifocal zones, as well as the edge shape being optimized to provide comfort without sacrificing tensile strength.
Proclear Multifocal Toric (omafilcon A) Soft (Hydrophilic) Contact Lens front surface is aspherical, with the anterior surface having a toric generated surface for the purpose of correcting vision in an eve that is astigmatic.
Proclear Sphere and Asphere: (omafilcon A) Soft (hydrophilic) Contact Lenses. The sphere lenses have spherical optical zone and asphere lens have an aspherical optical zone. This aspheric optical zone design (front surface) controls and limits the amount of longitudinal spherical aberration generated by the lens across the power range
6. Intended Use
Proclear Multifocal Toric (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with nondiseased eyes that are myopic or hyperopic which, possess astigmatism to -5.75 diopters or less, and are presbyopic.
Proclear Multifocal XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with nondiseased eyes that are myopic or hyperopic and are presbyopic. The lenses may be worn by persons who exhibit astigmatism of 0.75 diopters or less that does not interfere with visual acuity.
Proclear Toric XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with non-diseased eyes that are myopic or hyperopic which possess astigmatism corrections to -5.75 diopters.
Proclear Sphere and Asphere: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in non-aphakic persons with nondiseased eyes that are myopic or hyperopic and exhibit astigmatism of 2.00D or less that does not interfere with visual acuity.
Proclear Toric: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in non-aphakic persons with non-diseased eyes that are myopic or hyperopic The lens may be worn by persons who have astigmatism of 5.00D or less.
Proclear Multifocal: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of refractive ametropia (myopia, and astigmatism) and presbyopia in non-aphakic persons with non-diseased eyes. The lens may be worn by persons who have astigmatism of 2.00D or less that does not interfere with visual acuity.
Proclear (omafilcon A) Soft (hydrophilic) Contact Lenses may provide improved comfort for contact lens wearers who experience mild discomfort or symptoms related to dryness during lens wear associated with Evaporative Tear Deficiency or from Aqueous Tear Deficiency (non-Sjogren's only).
Daily wear replacement schedules may vary from patient and should be decided by eyecare practitioners in consultation with their patients.
2
Page 3 of 6
FREQUENT PLANNED REPLACEMENT WEAR
When prescribed for frequent planned replacement wear the lenses are to be cleaned, rinsed and disinfected each time they are removed from the patients' eye and discarded after the recommended wearing period prescribed by the eye care practitioner. The lenses may be disinfected using a chemical disinfection system
DISPOSABLE WEAR
When prescribed for Dally Disposable Wear the lens is to be discarded after each removal
7. Predicate Device(s)
Proclear Multifocal, Toric and Multifocal Toric (Omafilcon A) Soft Contact Lenses (K110099)
Proclear Sphere, Asphere, Toric, Multifocal and Multifocal Toric (Omafilcon A) Soft Contact Lenses (K061948)
8. Characteristics of Substantial Equivalence
The soft contact lenses have the following similarities to the predicate lenses which previously received 510(k) concurrence:
- have the same indicated use. .
- incorporate the same design, .
- incorporate the same materials.
- . have the same shelf life, and
- . are packaged and sterilized using the same materials and processes.
The modifications to the hydration and inspection do not change the lens specifications or characteristics.
In summary, the omafilcon A soft contact lenses described in this submission are, substantially equivalent to the predicate device.
9. Physiochemical Studies
Results from physical, optical and chemical properties were performed and indicate no change to physicochemical properties of the lenses. Change does not affect physicochemical properties of the lenses.
| Tested Characteristics Summary | Acceptance Criteria | Results |
|---|---|---|
| Total Extractables , Water content, Dk, | ||
| Light Transmittance, refractive index | ||
| tested per ISO 18369-4:2006 | ||
| Ophthalmic optics - Contact lenses - | ||
| Part 4: Physicochemical properties of | ||
| contact lens materials: section 4.2 | Equivalent to predicate | |
| lens and meet | ||
| tolerances in ISO | ||
| 18369-2:2006 | Pass |
3
| Material Comparison | ||
|---|---|---|
| Characteristic | Subject Device | Predicate Device |
| Product name | Proclear Toric | |
| Proclear Toric XR | ||
| Proclear Multifocal | ||
| Proclear Multifocal XR | ||
| Proclear Multifocal Toric | ||
| Proclear Sphere | ||
| Proclear Asphere | Proclear Toric | |
| Proclear Toric XR | ||
| Proclear Multifocal | ||
| Proclear Multifocal XR | ||
| Proclear Multifocal Toric | ||
| Proclear Sphere | ||
| Proclear Asphere | ||
| Material USAN Name | Omafilcon A | Omafilcon A |
| 510(k) number | This submission | K110099 for material |
| FDA Category (Group) | Group II Non-Ionic | |
| High Water | Group II Non-Ionic | |
| High Water | ||
| Manufacturing method | Finished Inside | |
| Polymerization System II | Finished Inside | |
| Polymerization System II | ||
| Curing | Thermal Cure | Thermal Cure |
| Sterilization | Moist Heat (steam) in | |
| validated Autoclave | Moist Heat (steam) in | |
| validated Autoclave | ||
| Packaging | Blister Pack | Blister Pack |
| Visibility tint | VAT Blue 6 | VAT Blue 6 |
| Package Saline buffers | ||
| and surfactant | Phosphate buffers | |
| PEG200 and Tween 80 | Phosphate buffers | |
| Tween 80 | ||
| Water Content | 59% ± 2% | 59% ± 2% |
| Refractive Index | 1.395 ± 0.005 | 1.395 ± 0.005 |
| Oxygen Permeability x 1011 | 21.05 | 21.05 |
| Light Transmission | >90% | >90% |
| Base Curve | 8.0 to 9.3 mm | 8.0 to 9.3 mm |
| Diameter | 13.6 to 15.2 mm | 13.6 to 15.2 mm |
| Power | -20.00 to +20.00 | -20.00 to +20.00 |
Table 1: Material characteristics of the omafilcon A lens before and after modification.
Comparison Conclusion: all the material characteristics for the omafilcon A lens are equivalent between the predicate lens and the subject lens is omafilcon A made using FIPSII process with modified wet process).
10. Toxicology Studies
Results from in-vivo and in-vitro studies were performed as support for this modification and indicate no issues of toxicity or biocompatibility with the modified lens. Change will not affect lenses ability to remain non-toxic and biocompatible with the ocular environment.
A series of in-vitro and in-vivo preclincal toxicology and biocompatibility tests were performed to assess the safety and effectiveness of the contact lens. All tests were conducted in accordance with the GLP regulation (21 CFR Part 56) or according to valid scientific protocols.
CooperVision 510(k) Summary - Proclear omafilcon A
4
| Test | Acceptance Criteria | Result |
|---|---|---|
| Cytotoxicity Test ISO 10993 - 5: | ||
| 1999: Biological Evaluation of | ||
| Medical Devices - Part 5: Tests | ||
| for In Vitro Cytotoxicity | All 3 monolayers exposed | |
| to the test article show no | ||
| grade greater than grade 2 | ||
| (reactivity mild) | Pass | |
| ISO Ocular Irritation | ||
| ISO 10993 - 10:2002: Biological | ||
| Evaluation of Medical Devices - | ||
| Part 10: Tests for Irritation and | ||
| Delayed Hypersensitivity | Test extract shows no | |
| significant irritation over the | ||
| reagent control during the | ||
| observation period. | Pass | |
| Systemic Toxicity Study | ||
| ISO 10993 - 11: 1996: Biological | ||
| Evaluation of Medical Devices - | ||
| Part 11: Tests for Systemic | ||
| Toxicity. | During the observation | |
| period, none of the animals | ||
| treated with the individual | ||
| test extract exhibit a | ||
| significantly greater | ||
| reaction that the control | ||
| animals. | Pass | |
| ISO Contact Lens 22 Day Ocular | ||
| Irritation Study | ||
| ISO 9394 Ophthalmic Optics - | ||
| Contact Lenses and Contact · | ||
| Lens Care Products - | ||
| The determination of | ||
| Biocompatibility by Ocular Study | ||
| with Rabbit Eyes. | Scores from macroscopic | |
| and microscopic ocular | ||
| examinations equivalent | ||
| between test and control | ||
| eyes. | Pass |
11. Conclusions of Non-Clinical Tests Performed:
Physiochemical: .
The physical, optical and chemical properties of this lens remain unchanged from the unmodified device, and are within established specifications for the lenses.
Toxicology: ■
Results from in-vivo and in-vitro studies conducted verify that the lenses remain non-toxic and are biocompatible with the ocular environment.
12. Clinical Studies
The technical characteristics, formulation, manufacturing, and sterilization processes of this lens are not changing and are equivalent to omafilcon A soft contact lenses currently marketed by CooperVision, therefore no clinical data is required.
Conclusion Drawn from Studies:
| Validity of | Contract laboratories under Good Manufacturing Practice regulations |
|---|---|
| Scientific Data | conducted toxicological and microbiology studies. |
| Chemistry, shelf-life and leachability studies were conducted by |
CooperVision 510(k) Summary - Proclear omafilcon A
5
CooperVision and followed scientific protocols. The data were determined to be scientifically valid under 21 CFR 860.7
Information presented in this Premarket Notification establishes that the Substantial CooperVision (omafilcon A) Proclear Toric XR, Proclear Multifocal and Equivalence Proclear Multifocal XR contact lens is as safe and effective as the predicate devices when used in accordance with the labeled directions for use and for the requested indications.
Risk and The risks of the subject lens are the same as those normally attributed to Benefits the wearing of soft (hydrophilic) contact lenses on a daily wear basis. The benefits to the patient are the same as those for other soft (hydrophilic) contact lenses.
6
Image /page/6/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird symbol, with three overlapping profiles forming the body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the bird symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
DEC 2 1 2011
CooperVision, Inc. C/O Lisa Hahn Global Regulatory Affairs 6150 Stoneridge Mall Road Pleasanton, CA 94588
Re: K112302
Trade/Device Name: Proclear (omafilcon A) Soft Contact Lenses Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) contact lens Regulatory Class: Class II Product Code: LPL and MVN Dated: November 17, 2011 Received: November 18, 2011
Dear Ms. Hahn:
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave roviewed your becermined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encroours) (c regirly and ment date of the Medical Device Amendments, or to connine.co province may 20, 1978, the eccordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The I ou may, merelore, mainet the act include requirements for annual registration, listing of general volulors provision practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability addition. Thease noter u, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean 1 that FDA has made a determination that your device complies with other requirements of the Act that I DA has intatutes and regulations administered by other Federal agencies. You must or any I each other of the Act's requirements, including, but not limited to: registration and listing (21
7
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical CFK Part 807), labeling (21 CFR 803); good manufacturing practice requirements as set device-related adverse events) (21 CFR Part 820); and if applicable, the electronic form in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice for your dovices/CDRH/CDRHOffices/ucm115809.htm for go to midth www.lua.gowritoour Drical Health's (CDRH's) Office of Compliance. Also, please the Center for Devices and Radions by reference to premarket notification" (21CFR Part note and regulations regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Tou may obtain of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Debra Falls
Image /page/7/Picture/7 description: The image shows a signature and the words "Mal" and "Dire". The signature is illegible, but it appears to be written in black ink. The words "Mal" and "Dire" are written in a simple, sans-serif font. The image is cropped, so it is not possible to see the full context of the signature and words.
Malvina B. Eydelman, M.D. Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure
8
Indications for Use
510(k) Number (if known): K112302
Device Name: Proclear (omafilcon A) Soft (hydrophilic) Contact Lenses
Indications for Use:
Proclear Multifocal Toric (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with nondiseased eyes that are myopic or hyperopic which, possess astigmatism to -5.75 diopters or less, and are presbyopic.
Proclear Multifocal XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with nondiseased eyes that are myopic or hyperopic and are presbyopic. The lenses may be worn by persons who exhibit astigmatism of 0.75 diopters or less that does not interfere with visual acuity.
Proclear Toric XR (omafilcon A) Soft (Hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in aphakic and not-aphakic persons with non-diseased eyes that are myopic or hyperopic which possess astigmatism corrections to -5.75 diopters.
Proclear Sphere and Asphere: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in non-aphakic persons with non-diseased eyes that are myopic or hyperopic and exhibit astigmatism of 2.00D or less that does not interfere with visual acuity.
Proclear Toric: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of visual acuity in non-aphakic persons with non-diseased eyes that are myopic or hyperopic The lens may be worn by persons who have astigmatism of 5.00D or less.
Proclear Multifocal: (omafilcon A) Soft (hydrophilic) Contact Lenses are indicated for daily wear for the correction of refractive ametropia (myopia, and astigmatism) and presbyopia in non-aphakic persons with non-diseased eyes. The lens may be worn by persons who have astigmatism of 2.00D or less that does not interfere with visual acuity.
Proclear (omafilcon A) Soft (hydrophilic) Contact Lenses may provide improved comfort for I round. (only arers who experience mild discomfort or symptoms related to dryness during lens wear associated with Evaporative Tear Deficiency or from Aqueous Tear Deficiency (non-Sjogren's only).
Page 1 of 2
9
Daily wear replacement schedules may vary from patient and should be decided by eyecare practitioners in consultation with their patients.
FREQUENT PLANNED REPLACEMENT WEAR
When prescribed for frequent planned replacement wear the lenses are to be cleaned, rinsed and disinfected each time they are removed from the patients' eye and discarded after the recommended wearing period prescribed by the eye care practitioner. The lenses may be disinfected using a chemical disinfection system
DISPOSABLE WEAR
When prescribed for Dally Disposable Wear the lens is to be discarded after each removal
Over-The-Counter Use Prescription Use X__ AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PI.EASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
J. Angelo Green
(Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
510(k) Number K112302
Page 2 of 2